Literature DB >> 33186710

Lessons From the 1918 Flu Pandemic: A Novel Etiologic Subtype of ADHD?

James M Swanson1, Nora D Volkow2.   

Abstract

In 2009, Dr. Anthony Fauci stated, "The 1918-1919 influenza pandemic was a defining event in the history of public health."1 In 2020, a popular medical website suggested that the 1918 pandemic may offer "lasting lessons for the world in the grip of COVID-19."2 One lesson from the 1918 pandemic relates to residual long-term effects. In his influential book published in 1971, Minimal Brain Dysfunction in Children, Wender3 reviewed historical accounts of the 1918 pandemic and suggested that viral infection had selective brain effects on catecholamine nuclei, and behavioral sequelae in some children emerged and overlapped with symptoms that now define attention-deficit/hyperactivity disorder (ADHD), and behavioral sequelae emerged in some adults that overlapped with symptoms of Parkinson's disease. Based on this and several excitotoxic models of behavioral disorders (ie, Volpe, Altman, Amsel, Benveniste, and Lou) related to arterial architecture and patterns of blood flow to the brain, previously our group4 proposed etiologic subtypes of ADHD based on a dopamine-deficit hypothesis and assumption that dopamine neurons might be particularly sensitive to a variety of environmental insults. We speculate that residual effects of 2019 novel coronavirus disease (COVID-19) may selectively affect brain regions underlying attention and motivation deficits associated with ADHD, as documented by positron emission tomography imaging studies of adults (see Volkow et al.5), which could increase risk for an infection-triggered etiologic subtype of ADHD.
Copyright © 2020 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 33186710     DOI: 10.1016/j.jaac.2020.09.024

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  5 in total

1.  Medical conditions and Attention-Deficit/Hyperactivity Disorder symptoms from early childhood to adolescence.

Authors:  Cédric Galéra; Samuele Cortese; Massimiliano Orri; Ophélie Collet; Judith van der Waerden; Maria Melchior; Michel Boivin; Richard E Tremblay; Sylvana M Côté
Journal:  Mol Psychiatry       Date:  2021-10-26       Impact factor: 15.992

Review 2.  Impact of COVID-19 for people living and working with ADHD: A brief review of the literature.

Authors:  Jack Hollingdale; Nicoletta Adamo; Kevin Tierney
Journal:  AIMS Public Health       Date:  2021-08-23

3.  Associations of Epstein-Barr Virus Infection with Attention Deficit Hyperactivity Disorder, Learning Disability, and Special Education in US Children.

Authors:  Jingjing Wang; Yaping Li; Xiaozhen Geng; Xin Zhang; Yanfeng Xiao; Wenjun Wang
Journal:  Int J Gen Med       Date:  2022-02-25

4.  Editorial Perspective: COVID-19, ADHD management and telehealth: uncertain path.

Authors:  Mark A Stein
Journal:  J Child Psychol Psychiatry       Date:  2022-02-09       Impact factor: 8.265

5.  Editorial Perspective: COVID-19-related publications on young people's mental health - what have been the key trends so far and what should come next?

Authors:  Samuele Cortese; Michel Sabe; Marco Solmi
Journal:  J Child Psychol Psychiatry       Date:  2022-04-19       Impact factor: 8.265

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.